# Apitoria Pharma Private Limited, Sangareddy, India – FDA Inspections

Source: https://www.keypedia.com/companies/apitoria-pharma-private-limited/7a543877-97f7-4c4a-8dc8-74ee9d1c0caf

> Inspection records and compliance data for Apitoria Pharma Private Limited in Sangareddy. 5 FDA inspections on record (1 OAI), 1 Form 483, last inspected November 18, 2022.

---

## Details

- Name: Apitoria Pharma Private Limited
- FEI Number: 3006370489
- Facility Type: Active Pharmaceutical Ingredient Intermediate Manufacturer
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING
- Address Line 1: Unit-III, Hathnoora Mandal, 374 Gundla Machanur Village
- City: Sangareddy
- Country Name: India
- Address: Unit-III, Hathnoora Mandal, 374 Gundla Machanur Village, Sangareddy, India
- Country: India

## Related Documents

- [483 - Apitoria Pharma Private Limited - 2022-11-18](https://www.keypedia.com/records/483/apitoria-pharma-private-limited/0ca5c5f3-e631-4d6e-81ed-de043814efd9) — source: FDA, date: November 18, 2022
- FDA Inspection 1192141 - Apitoria Pharma Private Limited - 2022-11-18 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 18, 2022
- [483 - Apitoria Pharma Private Limited - 2019-02-02](https://www.keypedia.com/records/483/apitoria-pharma-private-limited/413edfc9-6cdb-41b0-851f-7ffd80aed504) — source: FDA, date: February 2, 2019
- [FDA Inspection 1081175 - Apitoria Pharma Private Limited - 2019-02-02](https://www.keypedia.com/records/fda_inspections/apitoria-pharma-private-limited/3aa5f215-66af-4a2f-b199-2533dae5e1d0) — classification: Official Action Indicated (OAI), source: FDA, date: February 2, 2019
- FDA Inspection 1063274 - Apitoria Pharma Private Limited - 2018-05-10 — classification: No Action Indicated (NAI), source: FDA, date: May 10, 2018
- FDA Inspection 921426 - Apitoria Pharma Private Limited - 2015-03-05 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 5, 2015
- FDA Inspection 792756 - Apitoria Pharma Private Limited - 2012-06-20 — classification: No Action Indicated (NAI), source: FDA, date: June 20, 2012

## Related Companies

- [Teva API India Private Ltd.](https://www.keypedia.com/companies/teva-api-india-private-ltd/aeeb5a05-7558-44f6-a08a-bb2f3d1aa3de)
- [Roche Singapore Technical Operations Pte. Ltd.](https://www.keypedia.com/companies/roche-singapore-technical-operations-pte-ltd/e32730ce-85e1-4b01-8f9b-a8215d0593ca)
- [Eisai Co., Ltd. Kashima Plant](https://www.keypedia.com/companies/eisai-co-ltd-kashima-plant/70a3ccaf-c591-4ebf-952a-a2ee6a62e53c)
- [University of Missouri - Columbia Research Reactor Center](https://www.keypedia.com/companies/university-of-missouri-columbia-research-reactor-center/8b52f6ac-83c0-4557-834e-e421d6114e0b)
- [Aptuit (Oxford) Ltd.](https://www.keypedia.com/companies/aptuit-oxford-ltd/da0ef59c-f35f-478c-a844-0d223aa34b67)
- [Aldrich Chemical](https://www.keypedia.com/companies/aldrich-chemical/952e715f-08fa-455a-a0ae-f640e6a24704)
- [UBE Corporation](https://www.keypedia.com/companies/ube-corporation/76ca3dd5-0b44-4d3d-af9f-062d88ca7b3a)
- [Shilpa Pharma Lifesciences Limited](https://www.keypedia.com/companies/shilpa-pharma-lifesciences-limited/4f617c67-eea7-483d-b9c7-b1dd31aabcff)
- [Sumitomo Chemical Co., Ltd.](https://www.keypedia.com/companies/sumitomo-chemical-co-ltd/3ce10d51-6999-467f-ac0e-cb6696a98aa5)
- [Solara Active Pharma Sciences Limited](https://www.keypedia.com/companies/solara-active-pharma-sciences-limited/8f3f8236-f49d-43e3-84af-2cb404fb8264)

## Related Officers

- [Jose M. Cayuela](https://www.keypedia.com/people/jose-m-cayuela/3ee89bb5-4bba-493b-816f-31b8a9768025)
- [Pharmaceuticals ](https://www.keypedia.com/people/zedong-dong/8ef8185c-523a-4b16-ab37-863746d71787)
- [Lata C. Mathew](https://www.keypedia.com/people/lata-c-mathew/0610a0ef-dcc5-43e7-ab74-2ac54d758beb)
- [Arsen Karapetyan](https://www.keypedia.com/people/arsen-karapetyan/4000d909-277b-4533-992f-4e3627c8ce40)